BELGIUM researchers have found
hay fever medication could help
alleviate symptoms of irritable
bowel syndrome (IBS).
Researches from KU Leuven were
able to identify the link between
IBS sufferer’s hypersensitivity
and the larger quantities of the
substance histamine the patients
carry in their bodies.
KU Leuven gastroenterology
professor Guy Boeckxstaens and his
team have shown histamine has an
impact on the pain receptor TRPV1.
In IBS patients, histamine
released in the gut makes TRPV1
hypersensitive.
A pilot study found patients
who were treated with the
antihistamine ebastine for 12
weeks had significantly less
abdominal pain than the patients
from the control group.
A follow up study will evaluate the
drug on 200 IBS patients.The above article was sent to subscribers in Pharmacy Daily's issue from 15 Jan 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Jan 16
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.